See inside every stock. Pro
S&P 5007,723▲ 0.60%Nasdaq26,478▲ 1.18%Dow Jones52,378▲ 0.03%Nasdaq 10029,651▲ 1.29%VIX17.52▼ 4.73%US Dollar102.35▲ 0.39%Gold spot4,006▲ 0.30%WTI101.28▲ 1.38%
← AVL page
XStocksXray
Market X-Ray report · 27 October 2026

Australian Vanadium Ltd (AVL)

Australian Securities Exchange · Australia · prices in AUD · close of 27 Oct 2026

Key indicators

Last closeAUD 0.185
52-week range0.135 – 0.380
Return, 1 month / 3 months−21.3% / +32.1%
Return, 1 year / 3 years−43.1% / −71.5%
TrendBelow its 200-day average
RSI (14)46
Volatility (1 year)88.3%
Worst drawdown (1 year)-57.8%
Average daily value traded0.11M AUD
Dividend yield–

Market X-Ray price-based

55/ 100 · High confidence · ahead of 56% of stocks on this exchange
Trend60
Momentum61
Stability (higher is calmer)39
Liquidity62
Income–

Five-year price chart navy: price · brown: 200-day average

-0.010.681.382.082.772021-112023-022024-052025-082026-10

About the company

Australian Vanadium is a resource company based in Western Australia that explores for and develops vanadium deposits, with its main project located in the state's mid west region. The company also works on vanadium electrolyte production and energy storage through its subsidiary VSUN Energy, which supplies vanadium redox flow batteries and related systems to customers in the renewable energy and grid storage markets.

The shares are listed on the Australian Securities Exchange in Australia under the code AVL, and the price on this page is in Australian dollars (AUD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.

Summary

Australian Vanadium Ltd (AVL) trades on the Australian Securities Exchange in Australia. It last closed at AUD 0.185 on 27 October 2026.

Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 808 of 1,816 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.

Over the last year the price fell 43.1% and over the last three months it rose 32.1%. Returns are price returns, dividends not included.

Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.

stocksxray.com · page 1
XStocksXray
Australian Vanadium Ltd (AVL)

The five lenses in numbers each metric is ranked against the other stocks on Australian Securities Exchange

Lens and metricValueScoreReading
Trend60 · FairMixed trend against its averages.
Above 200-day average-10.3%
From 52-week high-43.1%
Momentum61 · FairTypical recent returns for this exchange.
3-month return32.1%
6-month return-19.6%
12-month return, skipping the last month-27.7%
Stability (higher is calmer)39 · WeakVolatile, with deep drawdowns.
Volatility, 1 year (lower is calmer)88.3%
Worst drawdown, 1 year (smaller is calmer)-57.8%
Liquidity62 · FairModerate trading activity.
Average daily value traded0.11M AUD
Zero-volume days0.0%
Income–Pays no dividend.
Dividend yield–
Years with dividends0

Strengths

No lens stands out as a clear strength against its exchange.

Weak spots

  • Stability (higher is calmer): Volatile, with deep drawdowns.

Returns

1 week+8.8%
1 month−21.3%
3 months+32.1%
6 months−19.6%
1 year−43.1%
3 years−71.5%
5 years−70.4%

Signals

50-day / 200-day average0.206 / 0.206
Golden / death cross (60 days)Golden, 0 days ago
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.014

Technical summary

DailyBearish3 bullish · 4 neutral · 9 bearish
WeeklyStrongly bearish2 bullish · 1 neutral · 9 bearish
MonthlyStrongly bearish0 bullish · 1 neutral · 7 bearish

How to read this report

Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Australian Securities Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.

stocksxray.com · page 2 · generated 28 Oct 2026